pSivida Corp. Share Price Nasdaq

Stocks

09/16/09	PSivida : Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle	PU
14/16/14	PSivida : Investigator-Sponsored Phase 2 Study Results Show pSivida's Medidur® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve	PU
02/16/02	PSivida : Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe	PU
28/15/28	PSivida : Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs	BU
14/15/14	PSivida : CEO to Present at Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015	BU

1 day

-0.87%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PSIVIDA CORP.	-0.87%	-2.40%	-	-	0
WUXI APPTEC CO., LTD.	-4.83%	+3.51%	+55.00%	+62.02%	6.67TCr
ARGENX SE	+0.02%	+1.07%	+11.72%	+75.63%	5.69TCr
LONZA GROUP AG	-1.34%	+2.98%	+25.08%	+100.18%	5.65TCr
BEONE MEDICINES AG	+5.09%	+9.89%	+27.19%	+103.27%	4.65TCr
IQVIA HOLDINGS INC.	+2.62%	+1.68%	+29.16%	+36.08%	4.48TCr
REVOLUTION MEDICINES, INC.	+8.24%	+0.51%	+215.16%	+807.84%	4.16TCr
CELLTRION, INC.	-1.86%	+10.13%	+28.14%	+55.48%	3.53TCr
GENMAB A/S	-2.97%	-9.84%	+90.91%	+73.49%	3.33TCr
INSMED INCORPORATED	+5.19%	+1.62%	-39.69%	+381.71%	2.51TCr
Average	+0.93%	+2.65%	+49.18%	+188.41%	4.52TCr
Weighted average by Cap.	+0.65%	+3.07%	+49.90%	+167.44%

Employees

Sector